lactic acid has been researched along with moxifloxacin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ahmad, Z; Khuller, GK; Pandey, R; Sharma, S | 1 |
| Hussain, T; Moin, A; Nagshubha, B; Raizaday, A | 1 |
| Devi, VK; Mustafa, S; Pai, RS | 1 |
| Garabadu, D; Handa, M; Kumar, R; Kushawaha, PK; Reddy, GA; Shukla, R | 1 |
5 other study(ies) available for lactic acid and moxifloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
Topics: Administration, Oral; Animals; Antitubercular Agents; Aza Compounds; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Resistance, Multiple; Drug Therapy; Econazole; Fluoroquinolones; Lactic Acid; Moxifloxacin; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Quinolines; Tuberculosis | 2008 |
Development and Optimization of Dual Drugs (Isoniazid and Moxiflox-acin) Loaded Functional PLGA Nanoparticles for the Synergistic Treatment of Tuberculosis.
Topics: Anti-Bacterial Agents; Drug Carriers; Drug Liberation; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Isoniazid; Lactic Acid; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Moxifloxacin; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Tuberculosis | 2016 |
Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Chitosan; Drug Carriers; Drug Liberation; Fluoroquinolones; Lactic Acid; Male; Microscopy, Electron, Transmission; Moxifloxacin; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Solubility; Tissue Distribution; Topoisomerase II Inhibitors; Water | 2017 |
Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and
Topics: Animals; Anti-Bacterial Agents; Drug Carriers; Drug Liberation; Lactic Acid; Mice; Moxifloxacin; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Transferrin | 2023 |